Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Expert Opinion on Therapeutic Patents|September 11, 2012
Phenylpiperazine derivatives: a patent review (2006 - present)Rodolfo do Couto Maia, Roberta Tesch, Carlos Alberto Manssour FragaExpert Opinion on Therapeutic Patents|September 13, 2014
Acylhydrazone derivatives: a patent reviewRodolfo do Couto Maia, Roberta Tesch, Carlos Alberto Manssour FragaCancers|August 7, 2021
The Small-Molecule Inhibitor MRIA9 Reveals Novel Insights into the Cell Cycle Roles of SIK2 in Ovarian Cancer CellsMonika Raab, Marcel Rak, Roberta Tesch, et al.ACS Chemical Biology|December 27, 2014
Identification and further development of potent TBK1 inhibitorsAndré Richters, Debjit Basu, Julian Engel, et al.European Journal of Medicinal Chemistry|May 17, 2019
Pyridinylimidazoles as dual glycogen synthase kinase 3β/p38α mitogen-activated protein kinase inhibitorsFabian Heider, Francesco Ansideri, Roberta Tesch, et al.ACS Chemical Biology|March 17, 2020
A Highly Selective Chemical Probe for Activin Receptor-like Kinases ALK4 and ALK5Thomas Hanke, Jong Fu Wong, Benedict-Tilman Berger, et al.Plos One|March 18, 2014
Novel potent imidazo[1,2-a]pyridine-N-Glycinyl-hydrazone inhibitors of TNF-α production: in vitro and in vivo studiesRenata B Lacerda, Natália M Sales, Leandro L da Silva, et al.European Journal of Medicinal Chemistry|November 26, 2013
Novel 2-chloro-4-anilino-quinazoline derivatives as EGFR and VEGFR-2 dual inhibitorsMaria Letícia de Castro Barbosa, Lídia Moreira Lima, Roberta Tesch, et al.Journal of Medicinal Chemistry|June 4, 2021
Structure-Based Design of Selective Salt-Inducible Kinase InhibitorsRoberta Tesch, Marcel Rak, Monika Raab, et al.Journal of Medicinal Chemistry|November 9, 2019
Fast Iterative Synthetic Approach toward Identification of Novel Highly Selective p38 MAP Kinase InhibitorsSandra Röhm, Benedict-Tilman Berger, Martin Schröder, et al.Pageof 2